|
1
|
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
|
J Infect Chemother
|
2003
|
1.73
|
|
2
|
Obstructive fibrinous tracheal pseudomembrane after tracheal intubation: a case report.
|
J Korean Med Sci
|
2010
|
1.05
|
|
3
|
Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance.
|
J Korean Med Sci
|
2010
|
1.02
|
|
4
|
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
|
Antimicrob Agents Chemother
|
2010
|
1.01
|
|
5
|
New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
|
Diagn Microbiol Infect Dis
|
2010
|
0.90
|
|
6
|
An abundant acyl-CoA (Delta9) desaturase transcript in pheromone glands of the cabbage moth, Mamestra brassicae, encodes a catalytically inactive protein.
|
Insect Biochem Mol Biol
|
2008
|
0.87
|
|
7
|
Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
|
Korean J Lab Med
|
2009
|
0.85
|
|
8
|
A case of pseudomembranous colitis associated with rifampin.
|
Korean J Intern Med
|
2004
|
0.84
|
|
9
|
Clinical experience of rigid bronchoscopy in single center.
|
Tuberc Respir Dis (Seoul)
|
2012
|
0.83
|
|
10
|
Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.
|
Bioorg Med Chem
|
2007
|
0.83
|
|
11
|
Bacteroides fragilis Toxin Induces IL-8 Secretion in HT29/C1 Cells through Disruption of E-cadherin Junctions.
|
Immune Netw
|
2013
|
0.80
|
|
12
|
Time sequence of airway remodeling in a mouse model of chronic asthma: the relation with airway hyperresponsiveness.
|
J Korean Med Sci
|
2007
|
0.77
|
|
13
|
Modification of cap group in delta-lactam-based histone deacetylase (HDAC) inhibitors.
|
Bioorg Med Chem Lett
|
2007
|
0.76
|
|
14
|
Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion.
|
Cancer Res Treat
|
2004
|
0.75
|